Clinical trial
INfecTive ENdocarditis After Transcatheter Aortic Valve Replacement (TAVR) a National SwEdish Study (INTENSE)
NCT03768180 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INfecTive ENdocarditis After Transcatheter Aortic Valve Replacement (TAVR) a National SwEdish Study (INTENSE)
- Lead sponsor
- Region Skane
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- August 1, 2019
- Enrollment
- 4,600 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infective endocarditis of aortic valve